永胜医疗控股有限公司（股票代码：01612）于2026年4月1日发布截至2026年3月31日的股份变动月报表。根据公告，公司于报告期内注册股本维持10,000,000,000股（面值每股0.01港元），总额仍为1亿港元，与上期持平。
本月前后已发行股份数由659,265,832股增加至659,395,832股，增幅130,000股，该增发股份主要来自公司购股权计划的行使。本月内因行使期权所得资金合计约为10.40万港元。公告显示，当月没有购回或注销股份的计划或行为，亦无库存股份数目变化。
至本月末，公司确认符合香港联交所关于最低公众持股量的要求，且所有新增发行均经过董事会批准并遵循相关法律及监管规定。该公告由公司秘书徐丽琪签署。公司表示将继续严格遵守香港联交所《上市规则》及适用法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.